TGFB1 and pulmonary fibrosis: Although TGF-β signals are attractive targets for lung fibrosis, genetic and pharmacological studies have indicated that broad targeting of general TGF-β signaling pathways might be problematic for treating fibrotic disease due to the pleiotropic roles of TGF-β (Mora et al., 2017; Saito et al., 2018).